AFP and hepatocellular carcinoma: Nevertheless, the combinatory use of C228T (−124G ≥ A) mutation with two biomarkers miR-122 expression and AFP levels acquired a good diagnostic performance in distinguishing HCC from LC (AUC = 0.88) or from the group without HCC (LC + CHB, AUC = 0.94).